Abstract
Our prediction model may be useful for predicting the long-term prognosis of seizures and their development after 3 years. Understanding the long-term prognosis during the initial treatment may facilitate the selection of appropriate treatment.
Introduction
Infantile Epileptic Spasms Syndrome (IESS), historically known as West Syndrome, is a severe form of childhood epilepsy characterized by clusters of spasms and a specific "chaotic" brainwave pattern called hypsarrhythmia. While treatments like ACTH and vigabatrin are standard, the long-term prognosis remains challenging: over half of these children experience significant developmental delays, and two-thirds suffer from long-term seizures. Early identification of patients at high risk for poor outcomes is critical for optimizing treatment strategies, such as considering early epilepsy surgery or ketogenic diets.
Methods
Researchers conducted a retrospective cohort study of 44 patients with IESS treated at Tottori University Hospital between 1996 and 2022. The study aimed to develop a simple clinical scoring system to predict outcomes at 3 and 7 years post-onset. Three primary risk factors were identified and assigned one point each:
- Persistence of spasms/tonic seizures: Continuing more than 90 days after onset.
- Developmental delay before onset: Defined as a Developmental Quotient (DQ) < 70.
- MRI abnormalities: Presence of moderate or severe abnormalities on neuroimaging.
Results
The scoring model demonstrated strong predictive power, particularly for 3-year outcomes. For seizure prognosis, a cutoff score of 2 yielded a sensitivity of 86.7% and a specificity of 64.3% (AUC = 0.825). For developmental prognosis, the model was even more robust, achieving 88.9% sensitivity and 100% specificity (AUC = 0.974) for predicting severe delay (IQ/DQ < 35).
At the 7-year follow-up, pre-existing developmental delay remained the most significant predictor of long-term cognitive outcomes, suggesting that the underlying etiology plays a dominant role in cognitive trajectory. Notably, every patient who had a poor outcome at 7 years had already been identified as having a poor outcome at the 3-year mark, suggesting the 3-year milestone is a reliable indicator of permanent trajectory.
Discussion and Conclusion
The study highlights a "golden window" for treatment; failure to control spasms within 90 days is a major red flag for long-term seizure persistence. Furthermore, the high specificity of the developmental model at 3 years suggests it can reliably identify children who will face severe long-term challenges. While limited by a small, retrospective sample from a single center, this clinical scoring system provides a practical tool for early prognostic counseling and treatment planning in IESS. Future multi-center studies are needed to validate these findings across broader populations.
Summary updated